Ashutosh Sachdeva, MD
Pulmonary Disease · Baltimore, MDNPI 1902019078
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Ambu A/s at 37.4% of the total. Among pulmonary disease clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 252 payments — averaging $403.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ambu A/s$38K
- Intuitive Surgical$16K
- Cook Incorporated$13K
- Fujifilm Healthcare Americas Corporation$4K
- AstraZeneca$3K
- Johnson & Johnson$3K
- plus $25K from 28 others
Across 4 payments — averaging $6445.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Erbe Elektromedizin GmbH$24K
- Gyrus ACMI, Inc.$1K
- Spiration, Inc.$1K
What the payments were for
- Consulting fees$56,01555%
- Speaking & faculty fees$17,62017%
- Travel & lodging$15,32915%
- Food & beverage$8,7609%
- Education$4,0004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ambu A/s | 6 | $38,040 |
| Intuitive Surgical | 91 | $15,754 |
| Cook Incorporated | 5 | $12,595 |
| Fujifilm Healthcare Americas Corporation | 4 | $3,820 |
| AstraZeneca | 10 | $3,494 |
| Johnson & Johnson | 19 | $3,471 |
| Merit Medical Systems Inc | 6 | $3,225 |
| Medtronic | 7 | $3,153 |
| Covidien LP | 27 | $3,134 |
| Coaptech, Inc. | 4 | $2,869 |
| Olympus America Inc. | 6 | $2,033 |
| Noah Medical Corporation | 8 | $1,843 |
| ERBE USA Inc | 4 | $1,779 |
| Pulmonx Corporation | 11 | $1,335 |
| Merck | 3 | $1,271 |
| Spiration, Inc. | 2 | $987 |
| Cook Medical LLC | 8 | $656 |
| Ambu Inc. | 7 | $493 |
| Boston Scientific | 4 | $358 |
| Galvanize Therapeutics, Inc | 4 | $254 |
| Pinnacle Biologics, Inc | 2 | $236 |
| Steris Corporation | 1 | $158 |
| United Therapeutics Corporation | 1 | $146 |
| Pleural Dynamics Inc. | 1 | $120 |
| Philips North America LLC | 1 | $97 |
| Body Vision Medical Inc. | 1 | $78 |
| Advanced Respiratory, Inc | 1 | $71 |
| Olympus Corporation Of The Americas | 2 | $70 |
| Gyrus ACMI, Inc. | 1 | $60 |
| Novocure Inc. | 1 | $38 |
| Vyaire Medical, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $23 |
| 4dmedical USA Inc | 1 | $22 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$14,245
- Cook Medical Ciaglia Blue Rhino$4,400
- Melker$4,125
- FUJIFILM$3,788
- Spiration Valve System$2,738
- PUMA SYSTEM$2,721
- superDimension$2,626
- Monarch Platform$2,153
- Erbe VIO APC CRYO$1,619
- MONARCH$1,030
- Cook Medical Needles$800
- GALAXY$687
- ZEPHYR ENDOBRONCHIAL VALVE$538
- AERO Stent and Delivery System$500
- Pulmonx Endobronchial Valve EBV$370
- Blue Rhino$355
- Photofrin$200
- VIO Cryo APC$160
- TRUFREEZE$158
- PUMA-G System$148
How this compares
$101,725 in reported general payments places this provider in the 90th percentile of 297 pulmonary disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $12,616 |
| Mycophenolate Mofetil | 11 | $526 |
| Prednisone | 27 | $98 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Baltimore
- Alan SchwartzBaltimore$1.3M
- Hitesh BatraBaltimore$611K
- Lonny YarmusBaltimore$582K
- Robert WiseBaltimore$389K
- Ko Pen WangBaltimore$280K
- Hans LeeBaltimore$277K
- Angela ArgentoBaltimore$269K
- Michael DrummondBaltimore$263K
- Jason AkulianBaltimore$231K
- Kathryn RobinettBaltimore$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.